G. Gentile

发表

D3 receptor assessment in vivo: PET with [11C]PHNO and SB-277011

M. Laruelle, E. Rabiner, R. Gunn, 2008 .

1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A Series of Potent and Selective Dopamine D3 Receptor Antagonists

J. Hagan, A. Schwarz, A. Capelli, 2007 .

Synthesis and pharmacological characterization of novel druglike corticotropin-releasing factor 1 antagonists.

A. Capelli, F. Blaney, S. Provera, 2008, Journal of medicinal chemistry.

Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system

L. Carboni, L. Caberlotto, M. Andreoli, 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: novel, potent, and selective series of Vasopressin 1b receptor antagonists.

A. Pozzan, F. Micheli, R. Di Fabio, 2010, Bioorganic & medicinal chemistry letters.

Synthesis of dimeric and tetrameric macrolactams with cytotoxic activity 1

M. Botta, D. Fattori, F. Corelli, 2000 .

Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies.

Yiyun Huang, M. Laruelle, R. Carson, 2009, Bioorganic & medicinal chemistry letters.

In vivo quantification of regional dopamine‐D3 receptor binding potential of (+)‐PHNO: Studies in non‐human primates and transgenic mice

Mark Slifstein, Christophe Plisson, Mickael Huiban, 2009, Synapse.

[3-azabicyclo[3.1.0]hex-1-yl]phenyl-benzenesulfonamides as selective dopamine D3 antagonists.

A. Prandi, C. Heidbreder, D. Donati, 2010, Bioorganic & medicinal chemistry letters.

Novel substituted tetrahydrotriazaacenaphthylene derivatives as potent CRF1 receptor antagonists.

A. Worby, G. Vitulli, F. Pavone, 2007, Bioorganic & medicinal chemistry letters.

RESEARCH ON ANTIVIRAL AGENTS. 5.1 LITHIATION OF 6-METHYLURACIL AS A NEW AND EFFICIENT ENTRY TO C(6)-SUBSTITUTED URACILS

M. Botta, R. Saladino, R. Nicoletti, 1996 .

5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors.

P. Bamborough, A. Bridges, S. Belyanskaya, 2012, Bioorganic & medicinal chemistry letters.

Researches on antiviral agents. 4. Studies on the chemistry of 6-methyl-2-methoxy-4-O-acyloxy and 6-methyl-2,4-di-O-acyloxypyrimidine derivatives as new acylation reagents and inhibitors of uracil DNA glycosylases.

M. Botta, R. Saladino, V. Summa, 1994 .

Researches on Antiviral Agents. Part 4. Studies on the Chemistry of 6‐ Methyl‐2‐methoxy‐4‐O‐acyloxy and 6‐Methyl‐2,4‐di‐O‐acyloxypyrimidine Derivatives as New Acylation Reagents and Inhibitors of Uracil DNA Glycosylases.

M. Botta, R. Saladino, V. Summa, 1994 .

The Synthesis of Enantiopure ω‐Methanoprolines and ω‐Methanopipecolic Acids by a Novel Cyclopropanation Reaction: The “Flattering” of Proline

U. Reinhold, S. Hanessian, G. Gentile, 1997 .

Chiral tetrahydroquinoline derivatives as potent anti-hyperalgesic agents in animal models of sustained inflammation and chronic neuropathic pain.

R. Barnaby, M. Corsi, E. Ratti, 2007, Bioorganic & medicinal chemistry letters.

Identification and evaluation of [11C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography

R N Gunn, M Laruelle, J. Passchier, 2010, Synapse.

1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.

A. Capelli, G. Tedesco, F. Blaney, 2010, Journal of medicinal chemistry.

Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system

L. Carboni, L. Caberlotto, M. Andreoli, 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists.

A. Capelli, G. Tedesco, C. Heidbreder, 2010, Journal of medicinal chemistry.